Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
0.5023
+0.0021 (0.42%)
At close: Oct 23, 2026, 4:00 PM EDT
0.4900
-0.0123 (-2.45%)
After-hours: Oct 23, 2026, 7:39 PM EDT
Oncolytics Biotech Employees
Oncolytics Biotech had 29 employees as of December 31, 2025. The number of employees increased by 1 or 3.57% compared to the previous year. That makes Oncolytics Biotech the 37,348th largest employer in the world and 5,209th in the United States.
Employees
29
Change (1Y)
1
Growth (1Y)
3.57%
Revenue / Employee
n/a
Profits / Employee
-$1,291,586
Market Cap
64.05M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 29 | 1 | 3.57% |
| Dec 31, 2024 | 28 | -1 | -3.45% |
| Dec 31, 2022 | 29 | 3 | 11.54% |
| Dec 31, 2021 | 26 | 1 | 4.00% |
| Dec 31, 2020 | 25 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 214 |
| Gossamer Bio | 162 |
| Heron Therapeutics | 128 |
| XBiotech | 87 |
| Fortress Biotech | 78 |
| Verrica Pharmaceuticals | 76 |
| Spero Therapeutics | 25 |
| Cingulate | 14 |
ONCY News
- 4 days ago - Oncolytics to present REO 033 trial in progress abstract at ESMO - TheFly
- 4 days ago - Oncolytics Biotech® to Present REO 033 Trial in Progress Abstract at ESMO Showcasing Pelareorep's Potential in Colorectal Cancer - GlobeNewsWire
- 10 days ago - Oncolytics Biotech® Provides Update on GOBLET Study Clinical Data and Final PanCAN Grant Payment - GlobeNewsWire
- 10 days ago - Oncolytics should be bought amid recent weakness, says Lake Street - TheFly
- 12 days ago - Oncolytics provides intellectual property portfolio update - TheFly
- 12 days ago - Oncolytics Biotech® Secures Patent Protection to Late 2040s and Provides Intellectual Property Portfolio Update - GlobeNewsWire
- 18 days ago - Oncolytics Biotech Proxy statement: Proxy filing - Filings
- 18 days ago - Oncolytics Biotech Proxy statement: Proxy filing - Filings